Alpha DNA Investment Management’s Zscaler ZS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-4,564
Closed -$879K 257
2024
Q1
$879K Buy
4,564
+479
+12% +$107K 0.32% 64
2023
Q4
$905K Sell
4,085
-1,194
-23% -$221K 0.35% 51
2023
Q3
$821K Sell
5,279
-2,095
-28% -$314K 0.34% 58
2023
Q2
$1.08M Sell
7,374
-4,483
-38% -$547K 0.36% 57
2023
Q1
$1.39M Sell
11,857
-728
-6% -$87.3K 0.41% 52
2022
Q4
$1.41M Buy
12,585
+8,288
+193% +$1.13M 0.5% 37
2022
Q3
$706K Sell
4,297
-3,059
-42% -$500K 0.59% 61
2022
Q2
$1.1M Buy
+7,356
New +$1.3M 0.94% 29
2022
Q1
Sell
-5,676
Closed -$1.82M 161
2021
Q4
$1.82M Sell
5,676
-392
-6% -$123K 1.15% 23
2021
Q3
$1.59M Sell
6,068
-1,514
-20% -$380K 1.08% 27
2021
Q2
$1.64M Buy
7,582
+2,301
+44% +$438K 1.12% 24
2021
Q1
$906K Buy
5,281
+5,273
+65,913% +$1.05M 1.04% 15
2020
Q4
$1K Buy
+8
New +$1.27K ﹤0.01% 561

Other funds holding ZS

Alpha DNA Investment Management's ZS Position: Q2 2024 in Review

Alpha DNA Investment Management sold out of Zscaler (ZS) in Q2 2024, closing a stake of 4,564 shares — an estimated $879K sold.

Alpha DNA Investment Management first reported a position in ZS in Q4 2020 and held it in 13 quarters. The position peaked at $1.82M in Q4 2021. 731 funds tracked by Wall St. Rank hold ZS as of Q2 2024.

  • Alpha DNA Investment Management reported no remaining Zscaler position as of Q2 2024 after selling out during the quarter.
  • Alpha DNA Investment Management sold 4,564 Zscaler shares in Q2 2024, an estimated $879K.
  • Alpha DNA Investment Management first reported a position in Zscaler in Q4 2020 and held it in 13 quarters.
  • Alpha DNA Investment Management's Zscaler position peaked at $1.82M in Q4 2021.
  • 731 funds tracked by Wall St. Rank held Zscaler as of Q2 2024.

Based on Alpha DNA Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.